Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 197,420,670
- Total 13F shares
- 19,461,984
- Share change
- -1,577,384
- Total reported value
- $29,679,262
- Price per share
- $1.52
- Number of holders
- 44
- Value change
- -$3,274,294
- Number of buys
- 16
- Number of sells
- 37
Report period
Q3 2019
Institutions
44
Top holders
10
ABUS full security history
Newer quarter: Q4 2019
Previous quarter: Q2 2019
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
2.8%
|
5,533,093
|
$11,509,000 | — | 30 Jun 2019 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2%
|
4,040,900
|
$8,405,000 | — | 30 Jun 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.9%
|
1,774,815
|
$3,692,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.82%
|
1,609,886
|
$3,349,000 | — | 30 Jun 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.53%
|
1,048,961
|
$2,182,000 | — | 30 Jun 2019 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.45%
|
885,000
|
$1,841,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.33%
|
658,289
|
$1,369,000 | — | 30 Jun 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.32%
|
627,999
|
$1,306,000 | — | 30 Jun 2019 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
0.31%
|
608,151
|
$1,265,000 | — | 30 Jun 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
521,025
|
$1,084,000 | — | 30 Jun 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.25%
|
500,000
|
$1,040,000 | — | 30 Jun 2019 | |
| NORGES BANK |
13F
|
Company |
0.19%
|
369,720
|
$769,000 | — | 30 Jun 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
304,340
|
$688,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
293,078
|
$610,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.11%
|
209,193
|
$435,000 | — | 30 Jun 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
200,736
|
$418,000 | — | 30 Jun 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
178,200
|
$371,000 | — | 30 Jun 2019 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
167,188
|
$348,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
166,409
|
$346,000 | — | 30 Jun 2019 | |
| Paloma Partners Management Co |
13F
|
Company |
0.08%
|
157,300
|
$327,000 | — | 30 Jun 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
147,482
|
$306,000 | — | 30 Jun 2019 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.06%
|
119,800
|
$249,000 | — | 30 Jun 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
88,106
|
$183,000 | — | 30 Jun 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
86,400
|
$180,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
76,695
|
$159,000 | — | 30 Jun 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
74,248
|
$155,000 | — | 30 Jun 2019 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.04%
|
73,098
|
$152,000 | — | 30 Jun 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
72,625
|
$150,000 | — | 30 Jun 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
65,848
|
$137,000 | — | 30 Jun 2019 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.03%
|
57,000
|
$129,000 | — | 30 Jun 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
43,479
|
$90,000 | — | 30 Jun 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
40,598
|
$84,000 | — | 30 Jun 2019 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
39,900
|
$83,000 | — | 30 Jun 2019 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.02%
|
35,449
|
$74,000 | — | 30 Jun 2019 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
32,584
|
$68,000 | — | 30 Jun 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.02%
|
30,593
|
$64,000 | — | 30 Jun 2019 | |
| LMR Partners LLP |
13F
|
Company |
0.01%
|
29,104
|
$61,000 | — | 30 Jun 2019 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
24,548
|
$51,000 | — | 30 Jun 2019 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.01%
|
22,650
|
$47,000 | — | 30 Jun 2019 | |
| ProShare Advisors LLC |
13F
|
Company |
0.01%
|
20,342
|
$42,000 | — | 30 Jun 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.01%
|
19,300
|
$40,000 | — | 30 Jun 2019 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
12,913
|
$27,000 | — | 30 Jun 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
11,959
|
$25,000 | — | 30 Jun 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
6,610
|
$14,000 | — | 30 Jun 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
5,247
|
$11,000 | — | 30 Jun 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
5,014
|
$10,000 | — | 30 Jun 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,784
|
$10,000 | — | 30 Jun 2019 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
4,542
|
$9,000 | — | 30 Jun 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3,962
|
$8,241 | — | 30 Jun 2019 | |
| Aperio Group, LLC |
13F
|
Company |
0%
|
1,234
|
$3,000 | — | 30 Jun 2019 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2019
As of 30 Sep 2019,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,461,984 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, PRIMECAP MANAGEMENT CO/CA/, LADENBURG THALMANN FINANCIAL SERVICES INC., MORGAN STANLEY, BANK OF MONTREAL /CAN/, Hudson Bay Capital Management LP, JENNISON ASSOCIATES LLC, BlackRock Inc., SPHERA FUNDS MANAGEMENT LTD., and NORGES BANK.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
56
Q3 2019 holders
44
Holder diff
-12
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.